254 related articles for article (PubMed ID: 15533890)
1. GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation.
Seargent JM; Yates EA; Gill JH
Br J Pharmacol; 2004 Dec; 143(8):933-7. PubMed ID: 15533890
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease.
Martin HL; Mounsey RB; Mustafa S; Sathe K; Teismann P
Exp Neurol; 2012 Jun; 235(2):528-38. PubMed ID: 22417924
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Magenta G; Borenstein X; Rolando R; Jasnis MA
BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
5. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
[TBL] [Abstract][Full Text] [Related]
6. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
[TBL] [Abstract][Full Text] [Related]
8. PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells.
Morgado M; Carson DD
J Cell Biochem; 2017 Jan; 118(1):163-171. PubMed ID: 27292441
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.
Morgenweck J; Abdel-Aleem OS; McNamara KC; Donahue RR; Badr MZ; Taylor BK
Neuropharmacology; 2010 Feb; 58(2):337-45. PubMed ID: 19891980
[TBL] [Abstract][Full Text] [Related]
10. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202.
Mody M; Dharker N; Bloomston M; Wang PS; Chou FS; Glickman TS; McCaffrey T; Yang Z; Pumfery A; Lee D; Ringel MD; Pinzone JJ
Endocr Relat Cancer; 2007 Jun; 14(2):305-15. PubMed ID: 17639046
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of rosiglitazone on the acid-induced intracellular generation of hydrogen peroxide in cultured feline esophageal epithelial cells.
Park SY; Sohn UD
Naunyn Schmiedebergs Arch Pharmacol; 2011 Feb; 383(2):191-201. PubMed ID: 21212935
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma activation inhibits progesterone-stimulated human MUC1 expression.
Wang P; Dharmaraj N; Brayman MJ; Carson DD
Mol Endocrinol; 2010 Jul; 24(7):1368-79. PubMed ID: 20484415
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
Zhou YB; Zhang J; Peng DQ; Chang JR; Cai Y; Yu YR; Jia MZ; Wu W; Guan YF; Tang CS; Qi YF
Cell Biochem Biophys; 2013 Jul; 66(3):421-9. PubMed ID: 23274912
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel.
Pavlov TS; Levchenko V; Karpushev AV; Vandewalle A; Staruschenko A
Mol Pharmacol; 2009 Dec; 76(6):1333-40. PubMed ID: 19752200
[TBL] [Abstract][Full Text] [Related]
18. Selective effects of PPARgamma agonists and antagonists on human pre-adipocyte differentiation.
Leyvraz C; Suter M; Verdumo C; Calmes JM; Paroz A; Darimont C; Gaillard RC; Pralong FP; Giusti V
Diabetes Obes Metab; 2010 Mar; 12(3):195-203. PubMed ID: 19895635
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor β/δ and γ agonists differentially affect prostaglandin E2 and cytokine synthesis and nutrient transporter expression in porcine trophoblast cells during implantation.
Blitek A; Szymanska M
Theriogenology; 2020 Aug; 152():36-46. PubMed ID: 32361305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
